Estimating Risk of Guillain-Barré Syndrome in US Medicare-Enrolled Older Adults Following Medically Attended Respiratory Syncytial Virus Disease: A Self-Controlled Case Series Analysis ✅ Just Accepted 🔗 https://bit.ly/3K5GQsu

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023 ✅ Just Accepted 🔗 https://bit.ly/4oPBYae

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023 ✅ Just Accepted 🔗 https://bit.ly/4oPBYae

Home testing for contagious illness: historical context and modern caveats ✅ Just Accepted 🔗 https://bit.ly/4rlkXGG

Is Seasonal Malaria Chemoprevention with Sulfadoxine-Pyrimethamine/Amodiaquine Appropriate in East Africa? ✅ Just Accepted 🔗 https://bit.ly/3K16n67

Pharmacometric evaluation of sulfadoxine-pyrimethamine-amodiaquine and dihydroartemisinin-piperaquine seasonal malaria chemoprevention in northern Uganda ✅ Just Accepted 🔗 https://bit.ly/44gr5pv

Artificial Intelligence and the Future of Healthcare-Associated Infection Surveillance: Bridging Precision, Partnership, Practice, and People ✅ Just Accepted 🔗 https://bit.ly/49jnzhI

Using generative AI for healthcare-associated infection surveillance ✅ Just Accepted #IDSky

Rethinking the routine: Are repeat blood cultures necessary after completion of infective endocarditis treatment? ✅ Just Accepted 🔗 https://bit.ly/489rqwy

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults ✅ Just Accepted 🔗 https://bit.ly/48aRxTS

Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial. ✅ Just Accepted

Post Treatment Blood Cultures in Patients with Infective Endocarditis: Valuable, Inconsequential or Worse? ✅ Just Accepted 🔗 https://doi.org/10.1093/cid/ciaf618?utmsource=x&utmmedium=organic-social&utmcontent=%40CIDJournal&utmcampaign=CID-Article-Promotion

Screening for anal cancer is associated with real harms and questionable benefits ✅ Just Accepted 🔗 https://bit.ly/4qWQ9f6

Response to Cardiac Complications of Mycoplasma pneumoniae: Overlooked Confounders, Biomarkers, and Host-Driven Shifts ✅ Just Accepted 🔗 https://bit.ly/3JZgbxB

How has the IDCRC VTEU network shaped infectious diseases research? This CID supplement reveals the network's structure, impact, and future directions for the ID Community #IDSky ↪️ https://bit.ly/43lUFK4

Anal cancer screening: a balanced approach is necessary ✅ Just Accepted #IDTwitter 🔗 https://bit.ly/4oK9kra

Cardiac Complications of Mycoplasma pneumoniae: Overlooked Confounders, Biomarkers, and Host-Driven Shifts ✅ Just Accepted 🔗 https://bit.ly/4p317Oh

Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk ✅ Just Accepted 🔗 https://bit.ly/4nLQgqT

Let's Get It Started: Early ART after HIV Acquisition Reduces Non-AIDS-Defining Malignancies ✅ Just Accepted 🔗 https://bit.ly/47zpRbh

Combined use of ibalizumab and lenacapavir for the treatment of multidrug-resistant HIV-1: A case series ✅ Just Accepted 🔗 https://bit.ly/47zMvQO

Anal Human Papillomavirus Infection Progression to Disease Among Men Who Have Sex With Men ✅ Just Accepted 🔗 https://bit.ly/49qmvsv

New strategies for a vexing problem: injectables to the rescue for people with Multidrug-Resistant HIV ✅ Just Accepted 🔗 https://bit.ly/4ovrYCU

International Collaboration to Develop and Harmonize Drug Interaction Guidance for Nirmatrelvir/Ritonavir During COVID-19: Lessons Learned for Future Pandemic Preparedness ✅ Just Accepted 🔗 https://bit.ly/43TxFlJ

Balancing Innovation in Artificial Intelligence with Practical Sepsis Definitions ✅ Just Accepted 🔗 https://bit.ly/43ZJzKP

Recalibrating COVID-19 Booster Policy: Lessons From Hybrid Immunity and Global Equity Gaps ✅ Just Accepted 🔗 https://bit.ly/4oVUGMO

Operationalizing Sepsis Definitions with Artificial Intelligence: Toward Smarter Antibiotic Use ✅ Just Accepted 🔗 https://bit.ly/3Lskd24

Does oral antibiotic switching therapy show similar efficacy to intravenous administration for treating infective endocarditis? ✅ Just Accepted 🔗 https://bit.ly/3JNCW7x

Towards a wider use of oral antibiotic switch in infective endocarditis ✅ Just Accepted 🔗 https://bit.ly/490XDar

Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa ✅ Just Accepted 🔗 https://bit.ly/3JhtYzq

We cannot overcome the mediocrity of colistin ✅ Just Accepted #IDTwitter 🔗 https://bit.ly/47CpWJN

Small effects, big impact: Multiple win measures aid interpretation, but don?t forget the bigger picture ✅ Just Accepted 🔗 https://bit.ly/4hJSS7l

The win ratio should be complemented by other win statistics to provide a comprehensive picture of relative and absolute treatment effects: the case study of the REPRIEVE trial ✅ Just Accepted 🔗 https://bit.ly/4oqSQE6

Impact of discontinuation of contact precautions on healthcare-associated ESBL-producing Escherichia coli in a large tertiary care hospital: an interrupted time-series analysis ✅ Just Accepted 🔗 https://bit.ly/47t7eEk

Closing the Gap in Race-based Inequities for Seasonal Influenza Hospitalizations: A Modeling Study #IDSky

Congenital Toxoplasmosis: Fewer Clinical Signs at 3 Years of Age Over the Last 15 Years but Stable Risk of Materno-fetal Transmission #IDSky

Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY) #IDSky

HIV Infection and Long COVID: A RECOVER Program, Electronic Health Record–Based Cohort Study #IDSky

Analysis of antibody markers as immune correlates of risk of severe COVID-19 in the PREVENT-19 efficacy trial of the NVX-CoV2373 recombinant protein vaccine ✅ Just Accepted #IDSky 🔗 https://bit.ly/3X3UaAs

Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment ✅ Just Accepted #IDSky 🔗 https://bit.ly/3Ws4x0Q

AI in ID practice: diagnostics, stewardship, education & surveillance. CID wants papers exploring real-world benefits & risks. Proposals due Nov 2. Learn more ⬇️

A Rapid Test to Differentiate Viral from Bacterial Infections: Searching for the Holy Grail ✅ Just Accepted 🔗 https://bit.ly/4oK7PJ6

Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial) ✅ Just Accepted #IDSky

Community-Acquired Respiratory Virus Infections: A Threat to Long-Term Survivors After Allogeneic Stem Cell Transplant? #IDSky

Effects of Semaglutide on Cognitive Function in People with HIV: A Randomized Controlled Trial ✅ Just Accepted #IDSky

Transmitted HIV-1 Drug Resistance Among Newly Diagnosed Individuals in 31 Provincial-Level Administrative Divisions in China in 2023: A Cross-sectional Survey #IDSky

The Need for Lenacapavir Compulsory Licences in Ending the HIV Epidemic #IDSky

Long-Term Effectiveness of Financial Incentives for Not Prescribing Unnecessary Antibiotics to Children With Acute Respiratory and Gastrointestinal Infections: Japan's Nationwide Quasi-Experimental Study #IDSky

Congenital Toxoplasmosis: Fewer Clinical Signs at 3 Years of Age Over the Last 15 Years but Stable Risk of Materno-fetal Transmission #IDSky

C-reactive protein in TB meningitis: a viable biomarker for individualized care. ✅ Just Accepted #IDSky 🔗 https://bit.ly/3IXBkId

C-reactive protein in TB meningitis: signal, surrogate, or saboteur? ✅ Just Accepted #IDSky 🔗 https://bit.ly/4htsw9M